The effects of megestrol acetate on nutritional parameters in a dialysis population.

[1]  D. Schaid,et al.  Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia. , 1990, Journal of the National Cancer Institute.

[2]  N. Tchekmedyian.  Treatment of anorexia with megestrol acetate. , 1993, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[3]  D. Schaid,et al.  Body-composition changes in patients who gain weight while receiving megestrol acetate. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  N. Pavlidis,et al.  Megestrol acetate in cancer patients with anorexia and weight loss. A Hellenic Co-operative Oncology Group (HeCOG) study. , 1993, Acta oncologica.

[5]  D. Schaid,et al.  Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  J. V. Von Roenn,et al.  Megestrol Acetate in Patients with AIDS-related Cachexia , 1994, Annals of Internal Medicine.

[7]  F. Fang,et al.  Management of anorexic patients in radiotherapy: a prospective randomized comparison of megestrol and prednisolone. , 1994, Journal of pain and symptom management.

[8]  M. Dudley,et al.  Pharmacologic evaluation of megestrol acetate oral suspension in cachectic AIDS patients. , 1994, Journal of acquired immune deficiency syndromes.

[9]  M. Brady,et al.  Megestrol acetate for treatment of anorexia associated with human immunodeficiency virus infection in children. , 1994, The Pediatric infectious disease journal.

[10]  Randomized trials of megestrol acetate for AIDS-associated anorexia and cachexia. , 1994 .

[11]  N. Gebbia,et al.  Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer. , 1996, British Journal of Cancer.

[12]  Li Yh,et al.  Low dose megestrol increases serum albumin in malnourished dialysis patients. , 1996 .

[13]  J. Burrowes,et al.  The role of pharmaceutical agents in appetite stimulation in patients with end-stage renal disease , 1996 .

[14]  L. Mccann.  National kidney foundation dialysis outcomes quality initiative: Implications for renal dietitians , 1997 .